Claudia Valverde

8PUBLICATIONS
141CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma.

Javier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge

|Jan 09, 2025
Targeted Next-Generation Sequencing in Succinate Dehydrogenase-Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR Pathway.

Carlo María Cicala, Judit Matito, María Quindos

|Jan 09, 2025
Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.

Sara Ortega-Bertran, Juana Fernández-Rodríguez, Miriam Magallón-Lorenz

|Dec 11, 2024
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors.

J Andrew Livingston, Jean-Yves Blay, Jonathan Trent

|Oct 02, 2024
Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS).

Javier Martin-Broto, Roberto Diaz-Beveridge, David Moura

|Sep 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial.

David S Moura, Jesus M Lopez-Marti, Iva Benesova

Pageof 2

Frequent Collaborators

4 joint publications

Javier Martín-Broto

3 joint publications

Nadia Hindi

3 joint publications

David S Moura

2 joint publications

Silvia Stacchiotti